Skip to main content

Ablation Techniques for Barrett’s Esophagus and Dysplasia

  • Chapter
  • First Online:
Adenocarcinoma of the Esophagogastric Junction
  • 936 Accesses

Abstract

The availability of safe and effective endoscopic techniques has caused a major shift in the management of Barrett’s associated dysplasia and early cancer from primarily surgical to endoscopic therapy. Prior to contemplating endoscopic therapy, careful selection of patients is essential and best served by evaluation with multidisciplinary team at specialized centers. This requires detailed examination of Barrett’s segment with removal of nodules or suspicious areas with endoscopic mucosal resection and expert confirmation of dysplasia by at least two gastrointestinal pathologists. This should be followed by eradication of remaining Barrett’s segment with ablation and ongoing vigilant surveillance as recurrences have been reported. Endoscopic therapy is considered in Barrett’s associated intramucosal cancer, Barrett’s esophagus with high-grade dysplasia, confirmed cases of low-grade dysplasia, and rare instances of non-dysplastic Barrett’s such as those with long segment and family history as complete eradication of Barrett’s esophagus is associated with marked reduction in cancer risk. Palliative therapy with photodynamic therapy or cryotherapy can be considered in selected cases of inoperable cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berenson MM, Johnson TD, Markowitz NR et al (1993) Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium. Gastroenterology 104:1686–1691

    Article  CAS  PubMed  Google Scholar 

  2. Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206

    Article  CAS  PubMed  Google Scholar 

  3. Bergman JJGHM, Fockens P (2006) Ablating Barrett’s metaplastic epithelium: are the techniques ready for clinical use? Gut 55(9):1222–1223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288

    Article  CAS  PubMed  Google Scholar 

  5. Shaheen NJ, Overholt BF, Sampliner RE et al (2011) Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 141:460–468

    Article  PubMed  PubMed Central  Google Scholar 

  6. Phoa KN, van Vilsteren FGI, Weusten LAM et al (2014) Radiofrequency ablation vs endoscopic surveillance for patients with Barrett Esophagus and low-grade dysplasia. A randomized clinical trial. JAMA 311(12):1209–1217

    Article  CAS  PubMed  Google Scholar 

  7. Shaheen NJ, Greenwald BD, Peery AF et al (2010) Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 71:680–685

    Article  PubMed  PubMed Central  Google Scholar 

  8. Gosain S, Mercer K, Twaddell WS et al (2013) Liquid nitrogen spray cryotherapy in Barrett’s esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc 78(2):260–265

    Article  PubMed  Google Scholar 

  9. Greenwald BD, Dumot JA, Abrams JA et al (2010) Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc 71(4):686–693

    Article  PubMed  PubMed Central  Google Scholar 

  10. Canto MI, Gorospe EC, Shin EJ et al (2009) Carbon dioxide (CO2) Cryotherapy is a safe and effective treatment of Barrett’s Esophagus (BE) with HGD/Intramucosal Carcinoma. Gastrointest Endosc 69:AB341

    Google Scholar 

  11. Greenwald BD, Dumot JA, Horwhat D, Lightdale CJ, Abrams JA (2010) Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus 23:13–19

    Article  PubMed  Google Scholar 

  12. Dumot JA, Vargo JJ, Falk GW et al (2009) An open-label, prospective trial of cryospray ablation for Barrett’s esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 70:635–644

    Article  PubMed  Google Scholar 

  13. Overholt BF, Lightdale CJ, Wang KK et al (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62(4):488–498

    Article  PubMed  Google Scholar 

  14. Overholt BF, Wang KK, Burdick JS et al (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 66(3):460–468

    Article  PubMed  Google Scholar 

  15. Pacifico RJ, Wang KK, Wongkeesong LM et al (2003) Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin Gastroenterol Hepatol 1:252–257

    Article  PubMed  Google Scholar 

  16. Prasad GA, Wu TT, Wigle DA et al (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology 137:815–823

    Article  PubMed  Google Scholar 

  17. Grade AJ, Shah IA, Medlin SM et al (1999) The efficacy and safety of argon plasma coagulation therapy in Barrett’s esophagus. Gastrointest Endosc 50:18–22

    Article  CAS  PubMed  Google Scholar 

  18. Lewis CJ, Caplin S, Armstrong G et al (2003) Argon Beam Plasma Coagulation as an ablative therapy for high grade dysplasia in Barrett’s Oesophagus. Clin Gastroenterol Hepatol 1(4):258–263

    Article  PubMed  Google Scholar 

  19. Akhtar K, Byrne JP, Bancewicz J et al (2000) Argon Beam Plasma Coagulation in the management of cancers of the esophagus and stomach. Surg Endoscopy 14:1127–1130

    Article  CAS  Google Scholar 

  20. Sampliner RE, Faigel D, Fennerty MB et al (2001) Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high dose acid suppression: a multicenter study. Gastrointest Endosc 53:554–558

    Article  CAS  PubMed  Google Scholar 

  21. Sharma P, Bhattacharyya A, Garewal HS et al (1999) Durability of new squamous epithelium after endoscopic reversal of Barrett’s Esophagus. Gastrointest Endosc 50:159–164

    Article  CAS  PubMed  Google Scholar 

  22. Sharma P, Jaffe PE, Bhattacharyya A et al (1999) Laser and multipolar electrocoagulation ablation of early Barrett’s adenocarcinoma. Gastrointest Endosc 49:442–446

    Article  CAS  PubMed  Google Scholar 

  23. Wu J, Pan Y, Wang T et al (2014) Endotherapy versus surgery for early neoplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc 79(2):233–241

    Article  PubMed  Google Scholar 

  24. Titi M, Overhiser A, Ulusarac O et al (2012) Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett’s esophagus. Gastroenterology 143:564–566

    Article  PubMed  Google Scholar 

  25. Gray NA, Odze RD, Spechler SJ (2011) Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol 106:1899–1908

    Article  PubMed  PubMed Central  Google Scholar 

  26. Gupta N, Mathur SC, Dumot JA et al (2012) Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett’s esophagus? Gastrointest Endosc 75:11–18

    Article  PubMed  Google Scholar 

  27. Anders M, Lucks Y, El-Masry MA et al (2014) Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett’s esophagus [published online July 23, 2013]. Clin Gastroenterol Hepatol 12(3):405–410. doi:http://dx.doi.org/10.1016/j.cgh.2013.07.013

  28. Chennat J, Ross AS, Konda VJ et al (2009) Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc 70:417–421

    Article  PubMed  Google Scholar 

  29. Gupta M, Iyer PG, Lutzke L et al (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium. Gastroenterology 145:79–86

    Article  PubMed  PubMed Central  Google Scholar 

  30. Pasricha S, Bulsiewicz WJ, Hathorn K et al (2014) Durability and predictors of successful radiofrequency ablation for Barrett’s Esophagus. Clin Gastroenterol Hepatol 12(11):1840–1847

    Article  PubMed  PubMed Central  Google Scholar 

  31. Fitzgerald RC, di Pietro M, Ragunath K et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63:7–42

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prashanthi N. Thota .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Thota, P.N. (2017). Ablation Techniques for Barrett’s Esophagus and Dysplasia. In: Giacopuzzi, S., Zanoni, A., de Manzoni, G. (eds) Adenocarcinoma of the Esophagogastric Junction. Springer, Cham. https://doi.org/10.1007/978-3-319-28776-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28776-8_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28774-4

  • Online ISBN: 978-3-319-28776-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics